Takeda Pharmaceutical Co. Ltd. Sponsored ADR
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.25 USD
707.96 M USD
30.05 B USD
3.16 B
About Takeda Pharmaceutical Co. Ltd.
Sector
Industry
CEO
Christophe Weber
Website
Headquarters
Osaka
Founded
1781
IPO date
May 16, 1949
Identifiers
3
ISIN US8740602052
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064Yield to maturity
5.92%
Maturity date
Jul 5, 2064
US874060BD74
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060Yield to maturity
5.78%
Maturity date
Jul 9, 2060
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054Yield to maturity
5.74%
Maturity date
Jul 5, 2054
US874060AZ95
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050Yield to maturity
5.67%
Maturity date
Jul 9, 2050
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044Yield to maturity
5.58%
Maturity date
Jul 5, 2044
US874060AY21
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040Yield to maturity
5.35%
Maturity date
Jul 9, 2040
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034Yield to maturity
4.80%
Maturity date
Jul 5, 2034
US874060AX48
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030Yield to maturity
4.29%
Maturity date
Mar 31, 2030
TKDB
Takeda Pharmaceutical Company Limited 2.0% 09-JUL-2040Yield to maturity
4.19%
Maturity date
Jul 9, 2040
S
US82481LAD1
Shire Acquisitions Investments Ireland Designated Activity Company 3.2% 23-SEP-2026Yield to maturity
4.16%
Maturity date
Sep 23, 2026
See all TAK bonds
